You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Researchers used Thermo Fisher's Ion Torrent technology to generate the data, which will allow researchers to monitor the evolution of the pathogen in real time.
Researchers sequenced 25 Ebola genomes isolated from patients infected during the outbreak, publishing their results in Emerging Infectious Diseases.
At The Conversation, the University of Birmingham's Nick Loman writes about his group's efforts to bring genome sequencing and surveillance to disease outbreak sites.
In Nature this week: genetic variation in Sierra Leone Ebola virus, host adaptation in microsporidian pathogens, and more.
Xpert Ebola joins three other tests on the World Health Organization's list of in vitro diagnostics eligible for procurement in Ebola-affected countries.
Genome sequencing on almost 200 Ebola virus isolates from Sierra Leone pointed to a jump in genetic diversity in the virus from July to October of 2014.
Researchers plan to share Ebola and MERS viral sequence data more quickly.
The system uses off-the-shelf laboratory components and currently runs an Ebola assay based on isothermal amplification chemistry from Alere subsidiary TwistDx.
The Wall Street Journal profiles NewLink Genetics, a biotech company based in Iowa.
A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.
AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.
According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.
Time magazine looks into how liquid biopsies are changing cancer care.
In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.